您的位置: 首页 > 农业专利 > 详情页

Prognosis and risk assessment in stroke patients by determining the level of marker peptides
专利权人:
B.R.A.H.M.S. GMBH
发明人:
Andreas Bergmann,Nils Morgenthaler
申请号:
US13868351
公开号:
US10067063B2
申请日:
2013.04.23
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The present invention relates to a method for prognosis of an outcome or assessing the risk of a patient having suffered a stroke or a transient ischemic attack, comprising the determination of the level of at least one marker peptide in said sample said marker peptide selected from the group comprising ANP, AVP, ADM, ET-1, troponin, CRP, calcitonin and hGH or fragments thereof or its precursor or fragments thereof and attributing the level of said at least one marker peptides its precursor or fragments thereof with the prognosis of an outcome or assessing the risk for said patient.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充